Ionis Pharmaceuticals in (ions 1.75 06/15/28)
13F holders, Q2 2025 (June 30)6holders +1
1new positions
0sold out
$1.12avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were New York State Common Retirement Fund ($8.5M), Sonora Investment Management Group, LLC ($5.5M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.6M).
- Company
- Ionis Pharmaceuticals in (ions 1.75 06/15/28)
- CUSIP
- 462222AF7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2.1M |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 5,175,247 shares bought and 214,000 shares sold, net +4,961,247 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| New York State Common Retirement Fund | 0.01% | Add +63.6% | 8,108,000 | $8.5M |
| Sonora Investment Management Group, LLC | 0.41% | Reduce -3.9% | 5,285,000 | $5.5M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Add +0.0% | 2,500,000 | $2.6M |
| State of Wisconsin Investment Board | 0.01% | New | 2,000,000 | $2.1M |
| Nomura Holdings Inc. | 0.01% | Add +211.7% | 34,227 | $1.4M |
| Sei Investments Co. | 0.00% | No change | 262,000 | $275K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.